Edition:
United States

People: Veracyte Inc (VCYT.OQ)

VCYT.OQ on NASDAQ Stock Exchange Global Market

23.03USD
18 Apr 2019
Change (% chg)

$0.10 (+0.44%)
Prev Close
$22.93
Open
$22.71
Day's High
$23.47
Day's Low
$22.60
Volume
131,804
Avg. Vol
172,626
52-wk High
$26.75
52-wk Low
$5.50

Hall, Christopher 

Mr. Christopher M. Hall is no longer President, Chief Operating Officer of the Company, effective July 1, 2019. He served as our Chief Commercial Officer from March 2010 to September 2014. Prior to joining us, Mr. Hall served as Chief Business Officer of Celera Corporation, a diagnostics company focusing on personalized disease management, from October 2008 to February 2010. From August 2002 to February 2010, Mr. Hall served in various executive and senior positions at Berkeley HeartLab, Inc., a cardiovascular disease management company that was acquired by Celera in October 2007, including Chief Clinical Operations Officer and Vice President of Marketing. Mr. Hall holds a B.A. in Economics and Political Science from DePauw University and an M.B.A. from Harvard Business School.

Basic Compensation

Total Annual Compensation, USD 415,000
Restricted Stock Awards, USD 181,000
Long-Term Incentive Plans, USD --
All Other, USD 488,004
Fiscal Year Total, USD 1,084,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Bonnie Anderson

2,213,130

Christopher Hall

1,084,000

Keith Kennedy

792,685

John Bishop

113,575

Fred Cohen

100,850

Karin Eastham

111,363
As Of  30 Dec 2017